LSA
IMCR icon

Leonteq Securities AG’s Immunocore IMCR Stock Holding History

Leonteq Securities AG’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2K Sell
63
-741
-92% -$21.9K ﹤0.01% 1145
2026
Q1 		$24.2K Sell
804
-69
-8% -$2.23K ﹤0.01% 970
2025
Q4 		$30.3K Sell
873
-97
-10% -$3.42K ﹤0.01% 1031
2025
Q3 		$35.2K Sell
970
-301
-24% -$10.2K ﹤0.01% 939
2025
Q2 		$39.9K Sell
1,271
-56
-4% -$1.74K ﹤0.01% 889
2025
Q1 		$39.4K Buy
1,327
+702
+112% +$21.1K ﹤0.01% 865
2024
Q4 		$18.4K Sell
625
-25
-4% -$790 ﹤0.01% 985
2024
Q3 		$20.2K Buy
650
+244
+60% +$8.87K ﹤0.01% 909
2024
Q2 		$13.8K Buy
+406
New +$20.7K ﹤0.01% 953
2021
Q3 		– Sell
-1,000
Closed -$39K – 1175
2021
Q2 		$39K Buy
+1,000
New +$38.6K ﹤0.01% 868

Other funds holding IMCR

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Leonteq Securities AG's IMCR Position: Q2 2026 in Review

Leonteq Securities AG reduced its Immunocore (IMCR) stake by 92% in Q2 2026, selling an estimated $21.9K and leaving 63 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #1145.

Leonteq Securities AG first reported a position in IMCR in Q2 2021 and has held it in 10 quarters since. The position peaked at $39.9K in Q2 2025. 136 funds tracked by Wall St. Rank hold IMCR as of Q2 2026.

  • Leonteq Securities AG held 63 shares of Immunocore worth $2K as of Q2 2026.
  • Leonteq Securities AG sold 741 Immunocore shares in Q2 2026, an estimated $21.9K.
  • Immunocore made up ﹤0.01% of Leonteq Securities AG's portfolio in Q2 2026, its #1145 holding.
  • Leonteq Securities AG first reported a position in Immunocore in Q2 2021 and has held it in 10 quarters since.
  • Leonteq Securities AG's Immunocore position peaked at $39.9K in Q2 2025.
  • 136 funds tracked by Wall St. Rank held Immunocore as of Q2 2026.

Based on Leonteq Securities AG's 13F filing for Q2 2026, filed 27 Jul 2026.